uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications

• Line Hammer Dohn ,

  * E-mail: line.hammer.dohn@regionh.dk

  Affiliations Department of Oncology, Rigshospitalet, Copenhagen, Denmark, The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Helle Pappot,

  Affiliation Department of Oncology, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Benedikte Richter Iversen,

  Affiliation Department of Pathology, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Martin Illemann,

  Affiliations The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  ⨯
• Gunilla Høyer-Hansen,

  Affiliations The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  ⨯
• Ib Jarle Christensen,

  Affiliations The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  ⨯
• Peter Thind,

  Affiliation Department of Urology, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Lisbeth Salling,

  Affiliation Department of Urology, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Hans von der Maase,

  Affiliation Department of Oncology, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Ole Didrik Laerum

  Affiliations The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark, Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark

  ⨯